PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsVancomycin
Vancomycin
Firvanq, Vancocin, Vancomycin (vancomycin) is a small molecule pharmaceutical. Vancomycin was first approved as Vancocin hydrochloride on 1982-01-01. It is used to treat bacterial endocarditis, bacterial infections, diarrhea, neutropenia, and pneumococcal meningitis amongst others in the USA.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
nervous system diseasesD009422
cardiovascular diseasesD002318
hemic and lymphatic diseasesD006425
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Firvanq, Tyzavan, Vancocin, Vancomycin (discontinued: Vancocin, Vancoled, Vancomycin, Vancor)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Vancomycin hydrochloride
Tradename
Company
Number
Date
Products
VANCOCIN HYDROCHLORIDEANI PharmaceuticalsN-050606 RX1986-04-15
2 products, RLD, RS
FIRVANQ KITAzurityN-208910 RX2018-01-26
2 products, RLD, RS
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINERBaxterN-050671 RX1993-04-29
5 products, RLD, RS
TYZAVANHikma PharmaceuticalsN-211962 RX2019-02-15
7 products, RLD, RS
VANCOMYCIN HYDROCHLORIDEMylanN-209481 RX2018-07-10
5 products, RLD, RS
VANCOMYCIN HYDROCHLORIDEZhejiang Novus PharmaceuticalsN-210274 RX2023-01-20
7 products, RLD, RS
Show 1 discontinued
Vancomycin
Tradename
Company
Number
Date
Products
VANCOMYCINHikma PharmaceuticalsN-213895 DISCN2021-08-26
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
firvanqNew Drug Application2025-12-15
sterile vancomycin hydrochlorideANDA2010-12-22
tyzavanNew Drug Application2025-10-28
vancocinNew Drug Application2025-12-22
vancomycinANDA2024-07-19
vancomycin hclunapproved drug other2014-08-20
vancomycin hydrochlorideANDA2025-12-31
vancomycin hydrochloride for oral solutionNDA authorized generic2025-12-16
vancomycin hydrochloride vancomycin hydrochlorideANDA2021-07-19
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
neutropenia—D009503D70
postoperative complications—D011183—
diarrhea—D003967R19.7
bacterial infections—D001424A49
staphylococcal infections—D013203A49.01
bacterial endocarditisEFO_1000830D004697—
pneumococcal meningitisEFO_1001114D008586G00.1
pseudomembranous enterocolitisEFO_1001314D004761A04.7
Agency Specific
FDA
EMA
Expiration
Code
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, ALKEM LABS LTD
2024-02-25PC
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, HIKMA
2024-02-12CGT
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, AMNEAL
2023-12-20CGT
Patent Expiration
Patent
Expires
Flag
FDA Information
Vancomycin, Vancomycin, Xellia Pharms Aps
100398042035-11-06DPU-282
101886972035-11-06DPU-282
108499562035-11-06DP
110005672035-11-06DP
115176092035-11-06U-282
Vancomycin Hydrochloride, Vancomycin Hydrochloride, Xellia Pharms Aps
116282002035-11-06DP
Vancomycin Hydrochloride, Firvanq Kit, Azurity
104930282035-03-13DP
106880462035-03-13DP
109599462035-03-13DP
109599472035-03-13DPU-3104, U-3105
109599482035-03-13DPU-3104, U-3105
109599492035-03-13DPU-3104, U-3105
116386922035-03-13DP
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07A: Intestinal antiinfectives
— A07AA: Antibiotics, intestinal
— A07AA09: Vancomycin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01X: Other antibacterials in atc
— J01XA: Glycopeptide antibacterials
— J01XA01: Vancomycin
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA28: Vancomycin
HCPCS
Code
Description
J3370
Injection, vancomycin hcl, 500 mg
J3371
Injection, vancomycin hcl (mylan) not therapeutically equivalent to j3370, 500 mg
J3372
Injection, vancomycin hcl (xellia) not therapeutically equivalent to j3370, 500 mg
Clinical
Clinical Trials
676 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—626393372170
Communicable diseasesD003141———132593985
Clostridium infectionsD003015EFO_1000874A05.262327121575
Staphylococcal infectionsD013203—A49.01—411111440
Surgical wound infectionD013530——3411131139
SepsisD018805EFO_0001420A41.923642539
Bacterial infectionsD001424—A49171311335
BacteremiaD016470EFO_0003033R78.81—7713935
PneumoniaD011014EFO_0003106J18—4371630
DiarrheaD003967—R19.718123326
Show 82 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ColitisD003092EFO_0003872K52.9232—1017
AbscessD000038EFO_0003030——26——8
InflammationD007249MP_0001845—1—2—58
Cross infectionD003428————1—45
Cystic fibrosisD003550EFO_0000390E84221——5
ToxemiaD014115————1—45
KeratitisD007634—H16111—35
MeningitisD008581EFO_0000584G03——1—34
Pseudomonas infectionsD011552EFO_0001076A41.52121——4
EndophthalmitisD009877————1—23
Show 42 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UlcerD014456MPATH_579—33——410
ReinfectionD000084063——22——47
Autism spectrum disorderD000067877—F84.034——17
ObesityD009765EFO_0001073E66.921——36
Crohn diseaseD003424EFO_0000384K50—3——25
Respiratory tract infectionsD012141—J06.911——35
MelanomaD008545——41———4
Autistic disorderD001321EFO_0003758F84.011——24
Hematopoietic stem cell transplantationD018380——11——24
Gastrointestinal diseasesD005767——14———4
Show 46 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD016638——1———1112
PharmacokineticsD010599——1———67
OsteoarthritisD010003EFO_0002506M15-M191———45
Healthy volunteers/patients———3———14
Non-small-cell lung carcinomaD002289——3————3
Fecal microbiota transplantationD000069467——1———23
Foot ulcerD016523——1———23
Diabetes mellitusD003920EFO_0000400E08-E131———12
Human influenzaD007251EFO_0007328J11.11———12
Biliary atresiaD001656EFO_0004217Q44.22————2
Show 15 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Septic shockD012772—A48.3————44
MediastinitisD008480—J98.51————33
Pneumococcal pneumoniaD011018EFO_1001474J13————22
Bacterial meningitisD016920EFO_1000831G00————22
Acinetobacter infectionsD000151EFO_1000792—————22
HemorrhageD006470MP_0001914R58————22
Subarachnoid hemorrhageD013345EFO_0000713I60————22
Rheumatoid arthritisD001172EFO_0000685M06.9————22
Ununited fracturesD005599——————22
Knee injuriesD007718——————22
Show 114 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVancomycin
INNvancomycin
Description
Vancomycin is a complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile. It has a role as an antimicrobial agent, an antibacterial drug and a bacterial metabolite. It is functionally related to a vancomycin aglycone. It is a conjugate base of a vancomycin(1+).
Classification
Small molecule
Drug classantibiotics (Streptomyces strain)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O
Identifiers
PDB—
CAS-ID1404-90-6
RxCUI—
ChEMBL IDCHEMBL262777
ChEBI ID28001
PubChem CID14969
DrugBankDB00512
UNII ID6Q205EH1VU (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Vancomycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 24,844 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
41,963 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use